Session 3: Addressing vaccine demand with rapid deployment of mRNA manufacturing - Joe Makowiecki Published 2021-09-27 Download video MP4 360p Recommendations 27:22 Session 4: Aseptic Filling for mRNA LNPs - John Harmer 45:00 Accelerate development by outsourcing MRNA–LNP formulations to a CDMO 58:58 Clinical and Commercial Manufacturing of mRNA Therapeutics: Opportunities and Challenges 45:23 New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy 1:03:31 Lipid Nanoparticle Portfolio for Enabling Non-Viral Delivery - Dr. Anitha Thomas 28:05 Scaled Up Production of mRNA-LNPs: Strategies & Parameters 24:36 Manufacture of LNPs for RNA delivery 43:40 Optimized and Scalable LNP Composition for RNA Vaccine Delivery 1:01:44 Maximizing Yield and Purity in RNA-LNP Downstream Processing 51:54 Enabling and advancing mRNA-LNP medicines from concept to clinic 23:48 CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle Platform 38:49 Novel Ionizable Lipid Portfolio for Enabling Non-Viral Delivery 1:56:10 Sunlight: Optimize Health and Immunity (Light Therapy and Melatonin) 10:02 adam 03:33 Nano Particle synthesis 29:24 Biomimetic LNPs for Enhanced Targeting of Inflamed Tissue: What Are the Challenges? 09:39 RNA-Lipid Nanoparticle Platform for the Multi-step engineering of gene edited CAR-T cells. 02:25 NanoAssemblr Commercial Formulation System Overview 01:55 Lipid Nanoparticles (LNPs) for mRNA Delivery | What are Lipid Nanoparticles? 26:36 LNPs: Therapeutics for Acute Myeloid Leukaemia Similar videos 06:37 Tackling mRNA manufacturing challenges with Aldevron 31:08 Session 1: Translation of RNA Nanomedicines from Design to Clinical - Dr. Heinrich Haas 28:18 Accelerating Development of saRNA-Lipid Nanoparticle Vaccines 35:34 Session 6: Formulation and Process Development w. PNI's Biopharmaceutical Services - Dr. Lloyd Jeffs 24:01 Microfluidic Manufacturing of Multicomponent Lipid Nanoparticles for In Vitro pDNA Delivery 24:32 Development with the End in Mind: How to Bridge the Valley of Death. 28:16 Session 5: RNA Vaccine Development to Phase I - Dr. John Lewis 07:45 Nanomedicines: Materials, Manufacturing & Therapeutic Applications | James Taylor, CEO, PNI 09:49 S2: Characterization & Analysis of saRNA in Lipid Nanoparticles for Drug Delivery - Dr. Adam Crowe 02:01 Transfer RNAs Quantification in E.coli | Protocol Preview 29:38 Development of Self-Replicating Propagation-Defective RNAs as Next Generation Vaccine Candidates... 33:50 RNA Therapeutics: Going Beyond the Liver 1:00:32 Prof. Sebastian Kadener - APPD Lecture Series 58:58 Microfluidics 101 with Dolomite #9 Lipid Liposome nanoparticle generation 31:01 Rewolucja mRNA - czy jesteśmy świadkami przełomu w medycynie? 04:34 Circular RNA-Mediated Immunotherapy; A Promising Way To Go. 1:08:22 dr hab. Joanna Kowalska – „mRNA jako narzędzie walki z koronawirusem i nie tylko” 19:44 Session 2: mRNA LNP scale up for GMP Vaccine Production - Dr. Jason Coleman More results